Tag
Tempus AI
- Guardant Health gains European CE mark for ESR1 breast cancer test
- Tempus AI buys Personalis to strengthen AI‑driven cancer monitoring platform
- Cambridge researchers develop urine test that could detect lung cancer years earlier
- Ohio's 'Breath of Hope' Gala raises money for lung cancer research
- Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine
- Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI
- Tempus AI builds on FDA win with Median partnership for lung cancer detection
- The promises and perils of artificial intelligence: a Mugglehead roundup
- Alibaba Group gets FDA nod for cancer detection tool